- likes
- 133
Post
More than 300 million people worldwide live with a rare disease, and 72% of those conditions stem from genetic mutations. For many, treatment means managing symptoms for life. But what if science could move beyond treatment and toward cures? At Danaher, we help researchers accelerate breakthroughs in gene editing and cell therapy by combining cutting-edge technologies, operational excellence, and a culture of continuous improvement. This approach enables scientists to move from discovery to delivery without compromise. Making these therapies a reality means tackling science’s toughest challenges. Explore how our global ecosystem is charting a bold path forward to address rare diseases: https://lnkd.in/giXuTbhz